000 | 01964 a2200469 4500 | ||
---|---|---|---|
005 | 20250513032120.0 | ||
264 | 0 | _c19951024 | |
008 | 199510s 0 0 eng d | ||
022 | _a1077-9450 | ||
024 | 7 |
_a10.1097/00042560-199510020-00006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCollier, A C | |
245 | 0 | 0 |
_aSafety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex. _h[electronic resource] |
260 |
_bJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association _cOct 1995 |
||
300 |
_a150-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAIDS-Related Complex _ximmunology |
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBlood Chemical Analysis |
650 | 0 | 4 |
_aCD4 Immunoadhesins _xadministration & dosage |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aHIV Core Protein p24 _xanalysis |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
700 | 1 | _aCoombs, R W | |
700 | 1 | _aKatzenstein, D | |
700 | 1 | _aHolodniy, M | |
700 | 1 | _aGibson, J | |
700 | 1 | _aMordenti, J | |
700 | 1 | _aIzu, A E | |
700 | 1 | _aDuliege, A M | |
700 | 1 | _aAmmann, A J | |
700 | 1 | _aMerigan, T | |
773 | 0 |
_tJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association _gvol. 10 _gno. 2 _gp. 150-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00042560-199510020-00006 _zAvailable from publisher's website |
999 |
_c7551934 _d7551934 |